Genomic organization of the JEM-1 (BLZF1) gene on human chromosome 1q24: Molecular cloning and analysis of its promoter region

Genomics

Volumn 69, Issue 3, 2000, Pages 380-390

  Tong, J H ^a,b   Fant, X ^a   Benoit, G ^a   Chen, S J ^b   Chen, Z ^b   Lanotte, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CIS ACTING ELEMENT; DNA; LUCIFERASE; MESSENGER RNA; RETINOID; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR SP1;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CHROMOSOME 1Q; DNA SEQUENCE; EXON; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RNA TRANSLATION; TATA BOX;

ANIMALIA;

EID: 0034331229     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6347     Document Type: Article

References (45)

1. Issues in searching molecular sequence databases
2. Local alignment statistics
3. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
4. The ovalbumin gene sequence of putative control regions
5. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
6. Ovalbumin gene: Evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries
7. The downstream promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila
8. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. Clinical results
9. Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells
10. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents
11. CpG islands and genes
12. Purification of CpG islands using a methylated DNA binding column
13. A multiplicity of CCAAT box-binding proteins
14. A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities
15. JEM-1, a novel gene encoding a leucinezipper nuclear factor upregulated during retinoid-induced maturation of NB4 promyelocytic leukaemia
16. Retinoic acid causes an anteroposterior transformation in the developing central nervous system
17. Retinoids: Present role and future potential
18. All-trans retinoic acid and cyclic adenosine monophosphate cooperate in expression of leukocyte alkaline phosphatase in acute promyelocytic leukemia
19. Cellular biology and biochemistry of the retinoids
20. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor
21. Use of all trans retinoid acid in the treatment of acute promyelocytic leukemia
22. 3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice
23. CpG islands in chromatin organisation and gene expression
24. The biologic basis for the use of retinoids in cancer prevention and treatment
25. NB4: A maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
26. RAR gamme 2 expression is regulated through a retinoic acid response element embedded in Sp1 sites
27. 9-cis Retinoid acid stereoisomer binds and activates the nuclear receptor RXR-α
28. A survey of 178 NF-Y binding CCAAT boxes
29. Optimal alignments in linear space
30. The biology of eukaryotic promoter prediction - A review
31. Retinoic acid enhances the expression of interferon-induced proteins: Evidence for multiple mechanisms of action
32. A human retinoic acid receptor which belongs to the family of nuclear receptors
33. Large scale sequencing specific neural networks for promoter and splice site recognition
34. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic cell line
35. Core promoter architecture for eukaryotic protein-coding genes
36. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes
37. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene
38. Local application of retinoic acid to the limb bud mimics the action of the polarising region
39. JEM-1, a novel nuclear co-factor: Localisation and functional interaction with AP-1
40. Expression patterns of the JEM-1 gene in normal and tumor cells: Ubiquity contrasting with a faint, but retinoid-induced, mRNA expression in promyelocytic NB4 cells
41. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic)
42. Differentiation therapy in acute myelogenous leukemia (non-APL)
43. The transcriptional regulation of human aldehyde dehydrogenase I gene. The structural and functional analysis of the promoter
44. New agents for acute myelogenous leukemia